Even though the pharma giant s spokespeople keep insisting that it had already disseminated all its clinical trial data at meetings and other means including negative data GlaxoSmithKline PLC still "agreed Thursday to release negative data on the safety and effectiveness of its drugs to settle a lawsuit by New York's attorney general that accused the pharmaceutical maker of misrepresenting data on prescribing its antidepressant drug Paxil to children& The London-based company is the first major drug maker to agree to disclose all its studies. The company also will pay $2.5 million to the state as part of the settlement." To receive a weekly blog update, e-mail Sue.
0 comments
Hide comments
